Pneumococcal Antibodies, IgG
Streptococcus Pneumoniae Antibodies, 23 Serotypes
Test Codes
Mayo: PN23, EPIC: LAB6129, Beaker: XPNAB
Department
Send Outs
Specimen Collection Criteria
Collect (preferred specimen): One Gold-top SST tube.
Also acceptable: One plain Red-top tube.
Physician Office/Draw Specimen Preparation
Let specimen clot 30-60 minutes then centrifuge to separate serum from cells within two hours of collection. Transfer serum to a plastic transport tube and refrigerate (2-8°C or 36-46°F).
Preparation for Courier Transport
Transport: 0.5 mL serum, refrigerated (2-8°C or 36-46°F). (Minimum: 0.4 mL)
Rejection Criteria
- Hemolyzed specimens.
- Severely lipemic specimens.
- Specimens not collected and processed as indicated.
In-Lab Processing
Let specimen clot 30-60 minutes then centrifuge to separate serum from cells within two hours of collection. Transfer serum to a plastic transport tube and refrigerate (2-8°C or 36-46°F).
Transport: 0.5 mL serum, refrigerated (2-8°C or 36-46°F). (Minimum: 0.4 mL)
Storage
Specimen Stability for Testing:
Room Temperature (20-26°C or 68-78.8°F): unacceptable
Refrigerated (2-8°C or 36-46°F): 21 days
Frozen (-20°C/-4°F or below): 21 days
Specimen Storage in Department Prior to Disposal:
Specimen retention time is determined by the policy of the reference laboratory. Contact the Send Outs Laboratory with any questions.
Laboratory
Sent to Mayo Clinic Laboratories in Rochester, MN.
Performed
Monday – Friday.
Results available in 5-7 days.
Reference Range
By report.
Test Methodology
Microsphere Photometry.
Interpretation
By report.
Clinical Utility
- Pneumococci have approximately 83 antigentically specific capsular polysaccharides that confer type-specific immunity. S. pneumoniae is the most common cause of otitis media and pneumonia is children less than 2 years old. Geriatric patients and those at high risk (cardiopulmonary and liver disease, recent splenectomy) are also susceptible to pneumococcal infections.
- The diagnosis and management of patients with chronic recurrent infections often requires an assessment of the patient's immune status. This includes evaluations for various immunoglobulins (IgG; IgG subclasses 1,2,3,and 4; IgA; IgM; and IgE) and tests of the patient's antibody-forming capacity when challenged with appropriate vaccines (diphtheria, tetanus, influenzae, polyvalent pneumococcal vaccine). Antibody concentrations can be used to determine the immune status of individuals previously immunized with the pneumococcal vaccine. A poor immune response to the pneumococcal-specific antigens may be indicative of a humoral immune defect.
CPT Codes
86317 x 22.
LOINC: Type 4 86108-8, Type 9V 30153-1, Type 12F 85974-4, Type 18C 40913-6, Type 19F 86021-3, Type 23F 86061-9, Type 2 86039-5, Type 10A 86098-1, Type 11A 86122-9, Type 15B 40973-0, Type 17F 86009-8, Type 5 86130-2, Type 19A 40974-8, Type 20 86045-2, Type 22F 86052-8, Type 33F 40969-8, Type 6B 40905-2, Type 3 86081-7, Type 7F 40911-0,Type 9N 86166-6, Type 14 85992-6, Type 8 86148-4, Type 1 85954-6
Contacts
Send Outs Laboratory – RO
248-551-9045
Name: Send Outs Laboratory – RO
Location:
Phone: 248-551-9045
Last Updated
7/9/2021
Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.